PROTAC ER Degrader-10
PROTAC ER Degrader-10 is a potent PROTAC ER degrader and can be used for cancer research. PROTAC ER Degrader-10 is extracted from patent WO2021133886, example 36.
Product Specifications
CAS Number
2504911-58-2
UNSPSC
12352005
Target
Estrogen Receptor/ERR; PROTACs
Type
Reference compound
Related Pathways
PROTAC; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-er-degrader-10.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=C([C@@](C2=CC=C(N3CCC(CC3)CN4CCN(C5=CC=C(C(N(C6C(NC(CC6)=O)=O)C7=O)=O)C7=C5)CC4)C=C2)([H])[C@@](C8=CC=CC=C8)([H])CO9)C9=C1
Molecular Formula
C44H45N5O6
Molecular Weight
739.86
References & Citations
[1]Jie Fan, et al. Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer. Patent WO2021133886.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
2,3-Anhydro-4,6-O-benzylidene-N-(tert-butoxycarbonyl)-1,5-deoxy-1,5-imino-D-glucitol
ATRX / RAD54 (Alpha Thalassemia Mental Retardation) (23c), CF488A conjugate, 0.1mg/mL
